BNP Paribas Financial Markets’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21K Sell
2,525
-38,489
-94% -$319K ﹤0.01% 3768
2025
Q1
$250K Sell
41,014
-3,612
-8% -$22K ﹤0.01% 2772
2024
Q4
$282K Buy
44,626
+4,610
+12% +$29.1K ﹤0.01% 2852
2024
Q3
$200K Sell
40,016
-6,894
-15% -$34.5K ﹤0.01% 2542
2024
Q2
$287K Buy
46,910
+14,141
+43% +$86.4K ﹤0.01% 2293
2024
Q1
$364K Buy
32,769
+13,223
+68% +$147K ﹤0.01% 2362
2023
Q4
$219K Buy
19,546
+3,031
+18% +$34K ﹤0.01% 2467
2023
Q3
$124K Buy
16,515
+11,624
+238% +$87.3K ﹤0.01% 2598
2023
Q2
$43.2K Buy
4,891
+4,721
+2,777% +$41.7K ﹤0.01% 2885
2023
Q1
$1.41K Hold
170
﹤0.01% 3025
2022
Q4
$1.63K Hold
170
﹤0.01% 3090
2022
Q3
$1.38K Hold
170
﹤0.01% 3675
2022
Q2
$949 Sell
170
-3,286
-95% -$18.3K ﹤0.01% 3269
2022
Q1
$19.4K Buy
3,456
+3,224
+1,390% +$18.1K ﹤0.01% 3159
2021
Q4
$1.02K Sell
232
-24
-9% -$106 ﹤0.01% 3401
2021
Q3
$2.41K Sell
256
-128
-33% -$1.21K ﹤0.01% 3173
2021
Q2
$2.8K Sell
384
-2,412
-86% -$17.6K ﹤0.01% 3244
2021
Q1
$17.4K Sell
2,796
-1,420
-34% -$8.82K ﹤0.01% 3211
2020
Q4
$31.4K Sell
4,216
-997
-19% -$7.43K ﹤0.01% 3083
2020
Q3
$31.6K Buy
5,213
+4,404
+544% +$26.7K ﹤0.01% 3046
2020
Q2
$6.76K Buy
809
+747
+1,205% +$6.24K ﹤0.01% 3253
2020
Q1
$368 Hold
62
﹤0.01% 3538
2019
Q4
$402 Sell
62
-1,354
-96% -$8.78K ﹤0.01% 3595
2019
Q3
$6.81K Hold
1,416
﹤0.01% 3577
2019
Q2
$5.66K Sell
1,416
-1,244
-47% -$4.98K ﹤0.01% 3599
2019
Q1
$12.9K Buy
2,660
+2,465
+1,264% +$12K ﹤0.01% 3399
2018
Q4
$1.24K Sell
195
-175
-47% -$1.12K ﹤0.01% 3215
2018
Q3
$3.03K Hold
370
﹤0.01% 3528
2018
Q2
$3.86K Buy
+370
New +$3.86K ﹤0.01% 3507